MAGEA3 Antibody - C-terminal region (OAAB16514)

Data Sheet
 
Product Number OAAB16514
Product Page www.avivasysbio.com/magea3-antibody-c-terminal-region-oaab16514.html
Name MAGEA3 Antibody - C-terminal region (OAAB16514)
Molecular Weight 34747 Da
Isotype Ig
NCBI Gene Id 4102
Host Rabbit
Clonality Polyclonal
Concentration Approximately 0.5mg/ml. Actual concentration varies with each lot.
Alias Symbols HIP8, HYPD, CT1.3, MAGE3, MAGEA6
Product Format Liquid. PBS with 0.09% (W/V) sodium azide.
Description of Target MAGEA3 is a member of the MAGEA gene family. The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 80% sequence identity between each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are expressed at a high level in a number of tumors of various histologic types, and are silent in normal tissues with the exception of testis and placenta. The MAGEA genes are clustered on chromosome Xq28. They may be implicated in some hereditary disorders, such as dyskeratosis congenita.
Reconstitution and Storage Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles.
Datasheets/Manuals Printable datasheet for OAAB16514
Additional Information Function: Proposed to enhance ubiquitin ligase activity of RING- type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.
Tissue Location: Expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes and placenta. Never expressed in kidney tumors, Leukemias and lymphomas.
Application Info WB: 1:1000
FC: 1:10~50
IHC-P: 1:10~50
Immunogen This MAGEA3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 283-314 amino acids from the C-terminal region of human MAGEA3.
Uniprot ID P43357
Protein Name Melanoma-associated antigen 3
Protein Accession # NP_005353.1
Purification This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Gene Symbol MAGEA3
Predicted Species Reactivity Human
Application WB, FC, IHC-P
Predicted Homology Based on Immunogen Sequence Human
Image 1
Human breast carcinoma
MAGEA3 Antibody (C-term) (Cat. # OAAB16514) immunohistochemistry analysis in formalin fixed and paraffin embedded human breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of MAGEA3 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Image 2
Jurkat
MAGEA3 Antibody (C-term) (Cat. # OAAB16514) flow cytometric analysis of Jurkat cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
Image 3
Jurkat
The anti-MAGEA3 (C-term) Antibody (Cat.# OAAB16514) is used in Western blot to detect MAGEA3 in Jurkat lysate.
 

AVIVA SYSTEMS BIOLOGY manufactures and sells quality antibody products covering genome wide proteins.

AVIVA SYSTEMS BIOLOGY
10211 Pacific Mesa Blvd, Ste 401, San Diego, CA 92121 USA | Tel: (858)552-6979 | info@avivasysbio.com